» Authors » M M Breteler

M M Breteler

Explore the profile of M M Breteler including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 118
Citations 8262
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Ruiz A, Heilmann S, Becker T, Hernandez I, Wagner H, Thelen M, et al.
Transl Psychiatry . 2014 Feb; 4:e358. PMID: 24495969
To follow-up loci discovered by the International Genomics of Alzheimer's Disease Project, we attempted independent replication of 19 single nucleotide polymorphisms (SNPs) in a large Spanish sample (Fundació ACE data...
2.
Alizadeh B, Njajou O, Millan M, Hofman A, Breteler M, van Duijn C
Neurobiol Aging . 2007 Jul; 30(2):330-2. PMID: 17628213
Iron is a reactive oxygen species and has been implicated in the pathogenesis of Alzheimer's disease (AD). In a population-based cohort study, including 268 incident AD patients and 2079 control...
3.
Clarke R, Lewington S, Donald A, Johnston C, Refsum H, Stratton I, et al.
J Cardiovasc Risk . 2002 Mar; 8(6):363-9. PMID: 11873092
Background: In epidemiological studies, within-person variability in plasma total homocysteine (tHcy) measurements may dilute the association of 'usual' levels of tHcy with risk of cardiovascular disease, referred to as 'regression...
4.
in t Veld B, Ruitenberg A, Hofman A, Launer L, van Duijn C, Stijnen T, et al.
N Engl J Med . 2002 Jan; 345(21):1515-21. PMID: 11794217
Background: Previous studies have suggested that the use of nonsteroidal antiinflammatory drugs (NSAIDs) may help to prevent Alzheimer's disease. The results, however, are inconsistent. Methods: We studied the association between...
5.
Dermaut B, Roks G, Theuns J, Rademakers R, Houwing-Duistermaat J, Serneels S, et al.
J Neurol . 2002 Jan; 248(11):935-9. PMID: 11757955
We have previously reported a significant association between early-onset Alzheimer's disease (EOAD) and an allele in the promoter of presenilin 1 (PSEN1) significantly decreasing PSEN1 expression in vitro. For late-onset...
6.
van de Vijver D, Stricker B, Breteler M, Roos R, Porsius A, de Boer A
Pharm World Sci . 2001 Oct; 23(4):148-52. PMID: 11599201
Aim: The aim of this study was to determine whether use of antiparkinsonian drugs in pharmacy records can be used as a marker for patients with Parkinson's disease (PD). Method:...
7.
Sijens P, den Heijer T, de Leeuw F, de Groot J, Achten E, Heijboer R, et al.
Invest Radiol . 2001 Sep; 36(10):597-603. PMID: 11577270
Rationale And Objectives: To assess whether differences in cerebral atrophy and white matter lesions or in the presence of lactate and lipid signals can explain the observed differences in brain...
8.
Hak A, Pols H, Stehouwer C, Meijer J, Kiliaan A, Hofman A, et al.
J Clin Endocrinol Metab . 2001 Sep; 86(9):4398-405. PMID: 11549682
Insulin resistance, which is highly prevalent in the elderly, is suggested to be accompanied by an increased acute phase response. Until now, it is unclear whether cellular adhesion molecules are...
9.
Sijens P, den Heijer T, de Leeuw F, de Groot J, Achten E, Heijboer R, et al.
Eur Radiol . 2001 Aug; 11(8):1495-501. PMID: 11519564
Magnetic resonance spectroscopy was used to assess the presence of brain lactate and lipid signals, frequently associated with the presence of pathology, in healthy persons of 60-90 years old (n...
10.
Ruitenberg A, Kalmijn S, de Ridder M, Redekop W, Van Harskamp F, Hofman A, et al.
Neuroepidemiology . 2001 Aug; 20(3):188-95. PMID: 11490165
The aim of this study was to construct a prognostic model to predict the progression of Alzheimer's disease (AD). Prevalent and incident cases with AD came from the Rotterdam Study,...